Selected Approaches to Disrupting Protein-Protein Interactions within the MAPK/RAS Pathway

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The MAPK/RAS pathway is crucial in cell signaling and frequently dysregulated in cancers.
• KRAS mutations drive many aggressive cancers, necessitating novel therapeutic approaches.
• Targeting protein-protein interactions (PPIs) presents a promising strategy beyond direct KRAS inhibition.

Purpose of the Study:

• To review recent strategies for inhibiting RAS signaling by targeting PPIs.
• To focus on disruptions of PPIs involving key pathway components like SOS1, RAF, PDEδ, Grb2, and RAS.
• To provide an overview of emerging therapeutic avenues for KRAS-mutant cancers.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of protein-protein interactions (PPIs) within the MAPK/RAS pathway.
• Identification of key proteins and their interaction partners targeted for inhibition.

Main Results:

• Several strategies exist to inhibit RAS signaling by disrupting PPIs.
• Specific targets include interactions involving SOS1, RAF, PDEδ, Grb2, and RAS.
• Disrupting these PPIs shows potential for therapeutic intervention in KRAS-driven cancers.

Conclusions:

• Inhibiting RAS signaling through PPI disruption is a viable therapeutic strategy.
• Targeting specific PPIs offers a promising approach for treating KRAS-mutant cancers.
• Further research into these PPI-targeting strategies could lead to new cancer therapies.